From July 14, 2022 to September 30, 2022, the company has repurchased 6,658,500 shares, representing 1.18% for CNY 34.95 million. With this, the company has completed the repurchase of 6,658,500 shares, representing 1.18% for CNY 34.95 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.47 CNY | +5.67% | -6.09% | -27.08% |
1st Jan change | Capi. | |
---|---|---|
-27.08% | 34Cr | |
+48.39% | 77TCr | |
-6.13% | 35TCr | |
+20.61% | 33TCr | |
+10.00% | 30TCr | |
+18.87% | 25TCr | |
-1.96% | 22TCr | |
+11.11% | 22TCr | |
+5.80% | 16TCr | |
-2.50% | 16TCr |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.